Clinical Trial

Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HSK39297 in Subjects With Hepatic Impairment

Name: Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HSK39297 in Subjects With Hepatic Impairment — clinical trial record (NCT07152288)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The study is being conducted to compare the pharmacokinetics, safety, and pharmacodynamics of HSK39297 in subjects with mild to moderate hepatic impairment and normal hepatic function

Trial Details

NCT Number	NCT07152288
Lead Sponsor	Haisco Pharmaceutical Group Co., Ltd.
Conditions	Paroxysmal Nocturnal Hemoglobinuria (PNH)
Enrollment	24 participants
Start Date	2025-05-29
Primary Completion	2025-09 (estimated)
Study Completion	2025-11 (estimated)
Updated on ClinicalTrials.gov	2025-09-03